Investor (INVE) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
5 Nov, 2025Executive summary
Adjusted net asset value (NAV) increased 3% in Q2 2025 to SEK 961 billion, with listed companies delivering a 6% total return and Patricia Industries posting a -6% return due to lower multiples and currency headwinds.
Total shareholder return was -5% for the quarter, underperforming the SIXRX index's 3% gain.
Significant investment activity included SEK 1.2 billion in Ericsson, SEK 0.82 billion in EQT AB, and SEK 2.6 billion in Fortnox.
Patricia Industries completed the USD 2.2 billion acquisition of Nova Biomedical post-quarter, with USD 1.6 billion financed internally.
Leverage remained low at 1.2% of adjusted assets, supporting continued investment capacity.
Financial highlights
Adjusted NAV reached SEK 961 billion as of June 30, 2025; listed companies represent 71% of assets, Patricia Industries 19%, and EQT 10%.
Listed companies delivered a 6% total return, outperforming the SIXRX index (3%), driven by SAAB and ABB.
Patricia Industries saw a 6% decline in estimated market values, mainly from lower multiples and negative currency impact, partially offset by organic sales growth.
Investments in equity returned 4%, led by EQT AB's share price appreciation.
Major subsidiaries and 3 Scandinavia reported SEK 67 billion in sales and SEK 16.7 billion in EBITDA (last 12 months).
Outlook and guidance
Companies are focusing on cost efficiency and agility amid a turbulent environment, with ongoing scenario planning for tariffs and FX impacts.
Mölnlycke is accelerating efficiency improvements to offset FX and tariff impacts, aiming to return to historical EBITDA levels.
Strategy 2025-2030 emphasizes profitable growth, future-proofing, and maintaining a strong financial position.
Latest events from Investor
- NAV up 8% in Q2, 9% TSR, strong listed returns, robust M&A in Patricia Industries.INVE
Q2 20243 Feb 2026 - Record NAV, 8% return, and SEK 1.9bn in acquisitions amid challenging markets.INVE
Q3 20242 Feb 2026 - Net asset value up 14% to SEK 1,087bn, 15% return, and 8% dividend hike; leverage at 2.1%.INVE
Q4 202522 Jan 2026 - NAV up 20% to SEK 970bn, TSR 27%, dividend raised to SEK 5.20/share.INVE
Q4 20249 Jan 2026 - Q1 2025 saw a 3% NAV drop, 2% shareholder return, and a major life sciences acquisition.INVE
Q1 202521 Dec 2025 - Q3 2025 saw 7% NAV growth, 5% shareholder return, and major strategic acquisitions.INVE
Q3 202520 Oct 2025